Recombinant Dopamine Receptor d1 anticorps (C-Term)
Aperçu rapide pour Recombinant Dopamine Receptor d1 anticorps (C-Term) (ABIN6943115)
Antigène
Voir toutes Dopamine Receptor d1 (DRD1) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Fonction
- DRD1 Recombinant Antibody
-
Réactivité croisée
- Humain
-
Homologie
- Mouse,Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- Human Dopamine Receptor D1 between 400 to C-terminus
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB(1:500-2000)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Autre désignation
- DRD1
-
Sujet
-
Synonyms: D(1A) dopamine receptor, Dopamine D1 receptor, DRD1
Background: Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
-
ID gène
- 1812
-
UniProt
- P21728
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-